TWIST1 and colorectal carcinoma: In 2010, a Japanese study reported increased TWIST1 methylation levels in CRCs and adenomas vs. normal mucosa (median 55.7%, 25.6%, and 0.0%, respectively), and methylated TWIST1 was suggested to be a potential biomarker in early CRC, with 89.6% of accuracy [117].